We’re recruiting for an accomplished scientist with experience in the chemical sciences to join the Biochemistry and Bio-related Chemistry Branch (BBC) of the Division of Pharmacology, Physiology, and Biological Chemistry (PPBC). The successful applicant will have responsibility for both scientific and administrative management of a portfolio of grants (both research and training) and fellowships, to include: stimulating, planning, advising, directing, and evaluating program activities for the portfolio of research awards.
The BBC Branch in PPBC Division supports basic research in areas of biochemistry, bio-related chemistry, and the glycosciences. This position will include stewardship of grant awards related to creation of new synthetic methodologies, biosynthesis and structure of macromolecules, synthesis of natural products, development of novel medicinal agents and mimics of macromolecular function, and/or the chemical basis of regulation and catalytic properties of enzymes.
Applicants should have expertise in chemistry, chemical biology, biological chemistry, or biochemistry, and should have experience in applications of chemistry to biological systems and/or therapeutics (for example, organic synthesis and methodology; biological catalysis and regulation; biotechnology, biosynthesis and bioengineering; or chemical tools for manipulation of biological systems). Candidates should also have outstanding written and oral communication skills.
The position is included in the global recruitment for Health Scientist Administrators. The vacancy will only be open for five days, beginning on January 22, 2018. Do not hesitate to ask questions about this position or the recruitment process. In preparing an application, Applying for Scientific Administration Jobs at NIGMS may offer other useful information.
Not looking to become a Health Scientist Administrator right now? Please help us out by forwarding this information to others who might be interested in this opportunity.
We’re recruiting for an outstanding individual to serve as branch chief within our Division of Genetics and Developmental Biology (GDB). This person will oversee the scientific and administrative management of the Developmental and Cellular Processes (DCP) Branch and will be responsible for advising, directing, and evaluating program activities for a portfolio of research grants in one of the branch areas.
The GDB Division supports research into the cellular and molecular mechanisms that underlie inheritance, gene expression, and development. The DCP Branch focuses on the genetic and biochemical pathways that cells utilize in development and in normal physiological processes. The research supported by the branch spans the spectrum from the genetic basis of development and cell function to biochemical signaling pathways that underlie normal cell physiology. Candidates should have expertise in any area of research supported by the branch. Familiarity with NIH extramural funding as an applicant, reviewer, or NIH scientific administrator is a plus, and outstanding written and oral communication skills are essential.
This position is included in the global recruitment for Health Science administrators which will only be open for a few days beginning on January 22, 2018. For additional information about this position, see the announcement on the NIGMS website. In preparing an application, Applying for Scientific Administration Jobs at NIGMS may offer other useful information.
Not looking for a position right now? Please help us out by forwarding this information to others who might be interested in this opportunity.
I’d like to make you aware of a proposed reorganization of the Institute’s scientific divisions that we are considering.
Currently, NIGMS has four scientific divisions: Biomedical Technology, Bioinformatics, and Computational Biology (BBCB); Cell Biology and Biophysics (CBB); Genetics and Developmental Biology (GDB); and Pharmacology, Physiology, and Biological Chemistry (PPBC). We would like to shift to a structure in which there are only three scientific divisions: Biophysics, Biomedical Technology, and Computational Biosciences (BBCB); Genetics and Molecular, Cellular, and Developmental Biology (GMCDB); and Pharmacology, Physiology, and Biological Chemistry.
In broad strokes, the current CBB cell biology branch and most of the grants it manages would move to the new Genetics and Molecular, Cellular, and Developmental Biology division, and the CBB biophysics branch would move to the new Biophysics, Biomedical Technology, and Computational Biosciences division. A few grant portfolios from CBB would be transferred to the existing Division of Pharmacology, Physiology, and Biological Chemistry.
This proposed reorganization does not reflect any change in scientific emphasis or interests by the Institute. Rather, it is an attempt to improve the efficiency and effectiveness of our support for fundamental biomedical research, consistent with two goals outlined in our strategic plan [PDF, 702KB]: enhance the effectiveness of our support for fundamental biomedical research and improve the efficiency of our internal operations.
The proposed restructuring also includes establishing the Center for Research Capacity Building as a full division, consistent with its unique place in the Institute. In addition, based on a recommendation from the Steering Committee of the Office of Emergency Care Research (OECR), we plan to transfer the office to the National Institute of Neurological Disorders and Stroke (NINDS). Because of NINDS’ strong expertise in and support for clinical research related to emergency medicine, it is extremely well-suited to promoting the mission of OECR.
You might wonder what the proposed reorganization will mean for your current or future funding. Our commitment to funding fundamental biomedical research and research capacity building programs remains the same, so the amount of money allocated to these areas will not change as a result of the proposed reorganization. We also expect that most grantees will continue working with their current program directors and grants management specialists.
Soliciting input from the community is among the steps that need to occur before any changes can be implemented. We invite you to share your thoughts on these plans by commenting here or by email. Input will be received through December 4, 2017.
NIGMS has a longstanding commitment to graduate training and has for many years supported research training in 11 broad areas of basic biomedical science, including Behavioral-Biomedical Sciences Interface; Bioinformatics and Computational Biology; Biostatistics; Biotechnology; Cellular, Biochemical, and Molecular Sciences; Chemistry-Biology Interface; Genetics; Molecular Biophysics; Molecular Medicine; Pharmacological Sciences; and Systems and Integrative Biology.
With publication of the NIGMS’ new predoctoral training grant funding opportunity announcement, the list now includes Transdisciplinary Basic Biomedical Sciences. This new area is designed to broaden the scope of disciplines supported by an NIGMS training grant and increase the geographical distribution of institutions that might apply.
The transdisciplinary area is open only to a) institutions that currently do not have an NIGMS-funded institutional predoctoral T32 training program in any of the basic biomedical science disciplines listed above (with the exception of Behavioral-Biomedical Sciences Interface or Biostatistics), or b) institutions with current NIGMS-funded predoctoral T32 training programs that propose to merge two or more of their existing NIGMS-funded predoctoral training programs into a single program. Training supported in this area is expected to be broadly-based and multidisciplinary in nature and may be covered by the other NIGMS-supported areas of basic biomedical science disciplines, or may include other emerging area(s) within the NIGMS mission.
Applications for the Transdisciplinary Basic Biomedical Sciences area will be accepted for the May 25, 2018, receipt date and thereafter.
If you or your institution are considering applying for our Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) funding opportunity—a new initiative designed to promote biomedical entrepreneurship—don’t miss our upcoming webinar:
Wednesday, November 15, from 3:00-4:30 p.m. ET.
During the webinar, NIGMS and Center for Scientific Review staff will explain the goals and objectives of the initiative and answer your questions. You are encouraged to submit questions by November 13 to Krishan Arora.
To join the webinar, visit the WebEx meeting page . If you are unable to attend online, you can join by phone by calling 1-650-479-3208 from anywhere in the United States or Canada and entering the access code 628 562 389.
NIGMS Staff Participating in the November 15 Webinar:
Krishan K. Arora, Program Director, NIGMS
Joseph Gindhart, Program Director, NIGMS
Christy Leake, Grants Management Team Leader, NIGMS
Allen Richon, Scientific Review Officer, NIH Center for Scientific Review
Slides will be available on the IDeA website following the event.
We look forward to talking with you soon.
We’ve published a new funding opportunity announcement (FOA) to support multidisciplinary, collaborative team research in scientific areas within the mission of NIGMS. The Collaborative Program Grant for Multidisciplinary Teams (RM1) aims to support highly integrated, interdisciplinary teams working toward a common scientific goal. The RM1 program replaces NIGMS Program Project Grants (P01) and most of NIGMS’ P50 centers programs (with the exception of the Structural Biology of HIV/AIDS centers). The first receipt date for the new program is January 25, 2018.
RM1 applications should have a unified scientific goal within the NIGMS mission that requires a team with diverse perspectives and expertise in a variety of intellectual or technical areas. We are seeking projects that are challenging, ambitious, and innovative, with the potential to produce lasting advances in their fields.Unlike many larger programs, NIGMS Collaborative Program Grants require one integrated research plan and a separate management plan that addresses shared leadership, responsibility for decision making and resource allocation, and opportunities for professional development and credit. Optionally, the team can expand to support early stage investigators (ESIs) in pilot projects that enrich program objectives and help the ESIs obtain independent funding.
In general, we expect that the research supported by Collaborative Program grants will be the primary focus of the principal investigators (PIs) rather than being in addition to the main work going on in their individual laboratories. Guidelines for investigator effort and details about how the PIs’ other support will be considered when making funding decisions can be found in the FOA and on the Institute’s website. Interested applicants are strongly encouraged to discuss research plans with NIGMS staff before submission.
We’ve just released a new training funding opportunity announcement (FOA) specifically tailored for predoctoral graduate programs in the basic biomedical sciences. Through this FOA, we intend to encourage changes in biomedical graduate training that allow it to keep pace with the rapid evolution of the research enterprise, which is increasingly complex, quantitative, interdisciplinary, and collaborative.
The overarching objective of this new predoctoral T32 training program is to develop a diverse pool of well-trained scientists who have the following:
Because diversity at all levels is integral to research and training excellence, this FOA is also intended to fund outstanding research training environments that support trainees from all backgrounds, and to enhance diversity in the biomedical enterprise by paying particular attention to the inclusion of individuals from groups underrepresented in the biomedical sciences.
The goal is of this FOA is to enable the community to develop and implement innovative approaches to training and mentoring that will effectively and efficiently train future generations of outstanding biomedical scientists. This funding announcement is designed to allow biomedical graduate education to preserve the best elements of the current system, while enhancing the focus on the trainee development of the technical, operational, and professional skills needed to transition into successful and productive careers in the biomedical research workforce.
The new FOA will apply to all NIGMS predoctoral T32 training grants submitted for receipt dates beginning May 25, 2018, except the Medical Scientist Training Program, which will remain on the parent T32 announcement for now. Because this is a new funding announcement, all applications (including those from previously established programs) must be submitted as new (-01), however applicants may describe up to 15 years of outcomes in the narrative.
I’m delighted to congratulate four members of the NIGMS community who became Nobel laureates this week. Early this morning, the Nobel Academy announced Joachim Frank, Ph.D., of Columbia University as one of today’s winners of the Nobel Prize in chemistry for the development of cryo-electron microscopy, which simplifies and improves the imaging of biomolecules. On Monday, the Academy recognized current and former NIGMS grantees Jeffrey C. Hall, Ph.D., of the University of Maine; Michael Rosbash, Ph.D., of Brandeis University; and Michael W. Young, Ph.D., of Rockefeller University, with the Nobel Prize in physiology or medicine for their discoveries of molecular mechanisms controlling the circadian rhythm.
Our Institute has a strong track record of funding scientists who receive Nobel Prizes. Since its creation in 1962, NIGMS has supported the work of 87 Nobel laureates—43 in physiology or medicine and 44 in chemistry. These investigators perform cutting-edge basic research in many different organisms and experimental systems that is the foundation for understanding normal life processes and disease.
The importance of investigator-initiated basic biomedical research, the NIGMS bedrock, was summed up brilliantly during this morning’s Nobel Prize announcement . In response to a reporter asking why most of this week’s Nobel laureates are from the United States, Professor Göran K. Hansson, Secretary General of the Royal Swedish Academy of Sciences, stated:
The United States has … allowed scientists to perform fundamental research to focus on important questions in science; not forcing them to immediate applications, not controlling them in a political way; and that freedom combined with very good resources have been very helpful to the United States.
Dr. Hansson noted that the United States is not alone in its philosophy, also recognizing the MRC Laboratory of Molecular Biology in Cambridge, United Kingdom, and the European Molecular Biology Laboratory in Heidelberg, Germany, for providing resources for basic, foundational science “that have turned out to pay off in practical applications later on. …”
Once again, congratulations to Drs. Frank, Hall, Rosbash, and Young on their exceptional recognition. These are also great wins for basic, foundational biomedical research.
CRCB Search Committee Members:
Marie Bernard, National Institute on Aging
William Gern, University of Wyoming
Laura Gibson, West Virginia University Health Sciences Center
Patricia Hand, Mount Desert Island Biological Laboratory
Jill Heemskerk, National Institute of Biomedical Imaging and Bioengineering
Laura Stanek, Office of Human Resources, NIH
Brent Stanfield, National Institute of Diabetes and Digestive and Kidney Diseases
David Wilson, Tribal Health Research Office, NIH
Doug Wright, University of Kansas Medical Center
Dorit Zuk, National Institute of General Medical Sciences, Chair
Fred Taylor, distinguished leader of our Center for Research Capacity Building (CRCB), is planning to retire, and we’re embarking on a search for an outstanding individual to serve as the new CRCB director. CRCB supports research, research training, faculty development, and research infrastructure improvements in states that historically have not received substantial levels of research funding from NIH. It also supports faculty research development at institutions that have a historical mission focused on serving students from underrepresented groups, research and research capacity building directed by Native American and Alaska Native tribal organizations, and conducts a science education program designed to improve life-science literacy. CRCB is composed of four programs: Institutional Development Awards, Native American Research Centers for Health, Science Education Partnership Awards, and Support of Competitive Research.
The CRCB director will have the opportunity to set priorities, lead change, and strengthen the biomedical research enterprise across the United States. The center director reports to the NIGMS director and is a member of the NIGMS senior leadership team, which helps set policies and priorities for the Institute. There are also opportunities to participate in and advise on NIH-wide activities and collaborations with other federal agencies.
Candidates must possess an M.D., Ph.D., or equivalent degree in a field relevant to the position. The ideal candidate will have considerable research experience in basic, clinical, or translational biomedical science; a demonstrated understanding of the conditions that disproportionately affect underserved populations; and knowledge related to the NIGMS mission. In addition, candidates should possess recognized research management and leadership abilities.
For additional information and application instructions, please see the vacancy announcement. NIGMS will accept applications for at least 45 days from October 2, 2017, but it will not close the application process until a candidate has been selected.
As chair of the search committee, I ask for your help in identifying candidates for this crucial position and in sharing this information with others who might be interested.